Body Surface Area Predicts Plasma Oxaliplatin and Pharmacokinetic Advantage in Hyperthermic Intraoperative Intraperitoneal Chemotherapy

Annals of Surgical Oncology - United States
doi 10.1245/s10434-012-2790-8
Full Text
Abstract

Available in full text

Categories
OncologySurgery
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Neoadjuvant, Adjuvant and Long-Term Intravenous/Intraperitoneal Chemotherapy, Hyperthermic Intraperitoneal Chemotherapy, Early Postoperative Intraperitoneal Chemotherapy for Ovarian Cancer

Journal of Peritoneum (and other serosal surfaces)
2017English

Which Method to Deliver Hyperthermic Intraperitoneal Chemotherapy With Oxaliplatin? An Experimental Comparison of Open and Closed Techniques

Annals of Surgical Oncology
OncologySurgery
2010English

Hyperthermic Intraperitoneal Chemotherapy With Oxaliplatin for Peritoneal Carcinomatosis: A Clinical Pharmacological Perspective on a Surgical Procedure.

British Journal of Clinical Pharmacology
Pharmacology
2018English

Systemic Complications of the Bidirectional Intraoperative Chemotherapy With Intravenous Ifosfamide and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Using Cisplatin Plus Doxorubicin

Pleura and Peritoneum
Internal Medicine
2019English

Hyperthermic Intraperitoneal Chemotherapy With Oxaliplatin—Still Not the Standard of Care for Patients With Colorectal Peritoneal Metastases

British Journal of Clinical Pharmacology
Pharmacology
2019English

Outcomes After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Dissemination From Ovarian Neoplasms

American Journal of Surgery
MedicineSurgery
2011English

Hyperthermic Intraperitoneal Chemotherapy Does Not Improve Survival in Advanced Ovarian Cancer

Cancer
Cancer ResearchOncology
2019English

Hyperthermic Intraperitoneal Chemotherapy and Cytoreductive Surgery in the Management of Peritoneal Carcinomatosis

Cancer Control
MedicineOncologyHematology
2016English

A Multi-Center Randomized Trial to Evaluate Hematologic Toxicities After Hyperthermic Intraperitoneal Chemotherapy With Oxaliplatin or Mitomycin in Patients With Appendiceal Tumors

Journal of the American College of Surgeons
Surgery
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy